Research Paper
1,4-dihydropyridine derivatives are of interest because of their potential biological activity such as antihypertensive [1] [2] [3] [4] , antiinflammatory [5] and antiischemic activities [6] and also as calcium channel modulators of the nifedipine type [7] . Several methods have been described for the synthesis of 1,4-dihydropyridine [8] [9] [10] [11] [12] . Recently, some new 3,5-substituted 1,4-dihydropyridine derivatives were synthesized which exhibit pharmacological activities [13] [14] [15] [16] . Thosemicarbazone also has significant biological activities such as antitumour, fungicide, bactereocide, antiinflammatory, and antiviral activities [17] [18] [19] [20] . Keeping these observations in mind, the present study worked on the synthesis of a new series of 1,4-dihydropyridine derivatives and screened their level of anticonvulsant activity.
MATERIALS AND METHODS
Melting points were recorded in open capillary tubes and are uncorrected. The IR spectra were recorded in KBr on a FT -IR Shimadzu 8201pc (4000-400 cm -1 ) and ¹H NMR and ¹³CNMR were recorded on a Broker DRX-300 MHz. Mass spectra (EI) were obtained on a Joel JMS D-300 spectrometer operating at 70eV. Elemental analyses (C, H, N, and S) were undertaken using an Elementer analyser model vario EL III. The purity of the compounds was checked by thin layer chromatography (TLC) with silica gel plates.
Synthesis of diethyl 4-(furan-2-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxy late (1a):
A reaction mixture was made up of ethyl acetoacetate (2 mol), furualdehyde (1 mol) and ammonium hydroxide (1 mol) in methanol (20 ml). It was then heated and refluxed for 4 h. The obtained solid was filtered off, the solid was washed with water and recrystallized using absolute ethanol. The above procedure was followed for the synthesis of compounds (1b-g 
Synthesis of 2,2'-{[4-(furan-2-yl)-2,6-dimethyl-1 , 4 -d i h y d ro p y r i d i n e -3 , 5 -d i y l ] d i c a r b o n y l } dihydrazinecarbothioamide (2a):
A reaction mixture was made up of compound (1a) (0.1 mol), thiosemicarbazide dissolved in ethanol (30 ml) and a few drops DMSO. It was then heated under reflux for 10 h. The obtained solid was allowed to cool and then poured in to crushed ice. The solid was collected by filtration, washed with water and recrystallised using ethanol. The above procedure was followed for the synthesis of compounds (2b-g). Yield (70% 
, ' -{ [ 4 -( 4 -c h l o r o p h e n y l ) -, 6 -d i m e t h y l -
): δ 9.71 (s, 2H, NH 2 ), 9.41 (s, 1H
, ' -{ [ 4 -( 4 -n i t r o p h e n y l ) -, 6 -d i m e t h y l -1 , 4 -d i h y d ro p y r i d i n e -3 , 5 -d i y l ] d i c e r b o n y l } dihydrazinecarbothioamide (2e):

, ' -{ [ 4 -( 4 -m e t h o x y h e n y l ) -, 6 -d i m e t h y l -1 , 4 -d i h y d ro p y r i d i n e -3 , 5 -d i y l ] d i c a r b o n y l } dihydrazinecarbothioamide(2f):
2,2'-{[4-(4-dimethylnitrophenyl)-2,6-dimethyl-1 , 4 -d i h y d ro p y r i d i n e -3 , 5 -d i y l ] d i c a r b o n y l } dihydrazinecarbothioamide(2g):
Yield 
Anticonvulsant activity:
Anticonvulsant activity method described in the anticonvulsant drug development (ADD) program protocol [21, 22] . Compounds (2a-g) were screened for their anticonvulsant activity against the pentyleneteterzole induced convulsions. The Swiss albino-rats are weighing 150 g divided into 9 groups containing 5 animals in each group, the test compounds are dissolved in DMSO and doses at (50 and 100 mg/kg). Normal saline solution was intraperitoneally administered, followed 15 min later by an intravenous 48.7 mg dose of pentamethylenetrazole dissolved in physiological saline. Convulsions reports are presented in [ Table 1 ].
Assay group:
A solution of the compound being tested in physiological saline was intrapertioneally administered after 15 min a time that was considered sufficient for complete absorption, that same dose of pentamethyleneteterzole was administered.
Reference group:
Phenytoin (50 mg/kg) was dissolved in physiological saline. After 15 min the same dose of pentamethylenetetrazole was applied. The test was evaluated by maximal electrode induced convulsion method. The maximal electroshock seizure (MES) convulsions electroshock is applied through the corneal electrodes.
RESULTS AND DISCUSSION
A series diethyl 2,6-dimethyl-4-substituted phenyl-1,4-dihydropyridine-3,5-dicarboxylate derivatives (1a-g) were prepared as base by following the method previously described literature [23] . 2,6-dimethyl- 4-substitutedphenyl-1,4-dihydropyridine-3,5-dicarboxylate (1a-g) reacted with thiosemicarbazide to give 2,2'-{[4-(4-substituted aromatic alcohols)-2,6-dimethyl-1,4-dihydropyridine-3,5-diyl]dicarbonyl} dihydrazinecarbothio amide (2a-g) by hydrazinolysis method [24, 25] (Scheme 1). The Physical constants and percentage yields of all compounds are summarized in Table 2 . The IR spectrum of the compounds (1a-g) showed an absorption band at 3332 to 3354 cm‫¹-‬ due to the NH stretching, and another absorption band at 1741-1764 cm‫¹-‬ due to the carbonyl group present in the ester function. The compound 1b showed an absorption band for the Cl-C group at 837 cm‫¹-‬ and compound 1c showed an absorption band for the OH-C group at 1447 cm‫,¹-‬ the compound 1d showed an absorption bands at 1536 cm‫¹-‬ corresponding to (NO 2 -C). The ¹H NMR spectrum of compound (1a-g), showed a singlet at δ 8.11 to 8.41, attributable to NH protons present in 1,4-dihydropyridine ring, and another important singlet at δ 4.67 to 4.79 which was attributable to the 4-CH present in the 1,4-dihydropyridine ring. The IR spectrum of compounds (2a-g), showed an absorption band at 3320 to 3372 cm‫¹-‬ due to NH group present in the 1,4-dihydropyridine ring and, another absorption band at 3118-3198 cm‫¹-‬ which is due to the NH-C=O stretch. An absorption band for C=S group was observed at 1245 to 1272 cm‫.¹-‬ The ¹HNMR spectrum of (2a-g) showed a singlet at δ 8.41 -8.64 attributable to NH protons, present in the 1,4-dihydropyridinering. The NHCS and NH 2 groups showed a singlet at δ 2.02-2.12 and 9.14-9.82, respectively. The ¹³C NMR spectrum of compounds (2a-g) showed peaks at δ 163.1-166.2, corresponding to the 3,5-position of CONH in the pyridine ring, 181.1-184.6 corresponding to the 3,5-position of CS in the pyridine ring, 34.6-46.5 corresponding to 4-position of carbon in the pyridine ring and 18.2-19.7 corresponding to the 2,6-position of CH 3 in the pyridine ring, respectively. The mass spectrum of compound (2a) showed that the molecular ion peak at m/z 410.23 and base peak of the compound m/z 261.25. The mass spectral fragmentation of compound (2a) showed the Scheme 2. Fig. 1 indicates that effect of compounds (2a-g) on the duration of convulsions. Compounds (1a-g) were inactive at the doses tested while compounds (2a-g) have significant activity at 100 mg/kg concentration. The effect of compounds (2a-g) on neuronal excitability as measured by their influence on the percentage of animals affected by convulsions is shown in Table 1 . The compound (2a) had highly active compared with other compounds (2b-g) at both doses (50 and 100 mg / kg). Since a dose of 150 mg/kg caused no signs of toxicity during the 24 h following its administration to a group of animals, this can be beneficial for further studies. The compound (2a) has highly active due to the presence of furan ring in 4-position of 1,4-dihydropyridine ring. Pharmacological and further preclinical investigations are currently underway.
